Trek Financial’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.89M Buy
91,892
+952
+1% +$34.9K 0.18% 132
2026
Q2
$3.07M Buy
+90,940
New +$2.73M 0.15% 140

Other funds holding IDNA

Trek Financial's IDNA Position: Q3 2026 in Review

Trek Financial increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 1% in Q3 2026, buying an estimated $34.9K and bringing the position to 91,892 shares worth $3.89M. The position accounts for 0.18% of the portfolio, ranked #132.

Trek Financial first reported a position in IDNA in Q2 2026 and has held it in 2 quarters since. 81 funds tracked by Wall St. Rank hold IDNA as of Q3 2026.

  • Trek Financial held 91,892 shares of iShares Genomics Immunology and Healthcare ETF worth $3.89M as of Q3 2026.
  • Trek Financial bought 952 iShares Genomics Immunology and Healthcare ETF shares in Q3 2026, an estimated $34.9K.
  • iShares Genomics Immunology and Healthcare ETF made up 0.18% of Trek Financial's portfolio in Q3 2026, its #132 holding.
  • Trek Financial first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2026 and has held it in 2 quarters since.
  • 81 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2026.

Based on Trek Financial's 13F filing for Q3 2026, filed 29 Oct 2026.